A股收評:滬指升0.35%重上3200點 英偉達概念股、教育股大升 中藥股掀升停潮
格隆匯5月26日丨三大指數午後明顯拉昇,上證指數收升0.35%報3212點,深證成指升0.12%,創業板指跌0.66%,兩市1961股下跌,2825股上升,全日成交8205億元。 盤面上,英偉達概念股大升,算力、存儲芯片方向領升,勝宏科技升停,寒武紀大升15%,劍橋科技再創歷史新高;全國首箇中藥飲片集採平均降價29.5%,中藥板塊掀升停潮;“AI+”行情回暖,教育股升幅強勢,中公教育與新華網在京簽署合作協議,午後直線封板;汽配股、銀行、電力、醫療器械股活躍。另外,新能源板塊回落,隆基綠能創始人表示光伏行業已經出現了產能過剩的問題,光伏方向走勢低迷;乘用車股跌幅居前,舉報事件繼續發酵,長城汽車跌4%;煤炭開採、能源金屬、家電等股下跌。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.